The Control of Technology Alliances: An Empirical Analysis of the Biotechnology Industry

By Josh Lerner, Robert P. Merges. 2003

640 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Entrepreneurial alliances as contractual forms (2003, background): “Very little research, however, has been devoted to the specifics of alliance negotiation and the role of contract design in particular (e.g., Parkhe, 1993; Deeds & Hill, 1996; Lerner & Merges, 1998).”
Strategic alliances, venture capital, and exit decisions in early stage high-tech firms (2013, positive): “Both types of funding are especially important sources of private capital for biotechnology firms (Lerner and Merges, 1998, and Stuart, Hoang, and Hybels, 1999).”
University Innovation and the Professor's Privilege (2016, neutral): “These difference-in-difference regressions thus generally take the form:20 = + + + × + + (2) In the relevant regression models, we cluster standard errors at the individual level.”
Exploiting technological opportunities: the timing of collaborations (2003, positive): “Lerner and Merges (1998)examined how the allocation of control rights was related to project’s stage of development, but we know of no other longitudinal work that has examined how R&D collaboration is related to time.”
The Dynamics of the Transfer and Renewal of Patents (2008, background): “6Some of the studies that have used data on strategic alliances and licensing data are Arora [6]; Lerner and Merges [32]; Anand and Khanna [3]; Arora, Fosfuri and Gambardella [7]; Gans, Hsu, and Stern [14], etc.”